Barclays
MXCT icon

Barclays’s MaxCyte MXCT Stock Holding History

Barclays’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$165K Sell
147,325
-1,688
-1% -$2.07K ﹤0.01% 4074
2026
Q2 		$183K Sell
149,013
-14,049
-9% -$14K ﹤0.01% 3767
2026
Q1 		$115K Sell
163,062
-137,218
-46% -$128K ﹤0.01% 3971
2025
Q4 		$465K Buy
300,280
+8,639
+3% +$13.8K ﹤0.01% 3894
2025
Q3 		$461K Sell
291,641
-29,590
-9% -$51.4K ﹤0.01% 3861
2025
Q2 		$700K Buy
321,231
+206,459
+180% +$500K ﹤0.01% 3565
2025
Q1 		$313K Sell
114,772
-49,260
-30% -$194K ﹤0.01% 3810
2024
Q4 		$682K Sell
164,032
-1,733
-1% -$6.55K ﹤0.01% 3636
2024
Q3 		$645K Buy
165,765
+127,156
+329% +$536K ﹤0.01% 3620
2024
Q2 		$151K Sell
38,609
-40,623
-51% -$175K ﹤0.01% 3720
2024
Q1 		$332K Sell
79,232
-58,599
-43% -$275K ﹤0.01% 3837
2023
Q4 		$648K Buy
137,831
+106,266
+337% +$414K ﹤0.01% 3717
2023
Q3 		$98.5K Sell
31,565
-3,359
-10% -$13.5K ﹤0.01% 3606
2023
Q2 		$160K Sell
34,924
-42,954
-55% -$197K ﹤0.01% 3354
2023
Q1 		$385K Buy
77,878
+47,281
+155% +$233K ﹤0.01% 3442
2022
Q4 		$167K Buy
30,597
+19,377
+173% +$119K ﹤0.01% 3949
2022
Q3 		$72K Sell
11,220
-1,572
-12% -$8.77K ﹤0.01% 3660
2022
Q2 		$61K Sell
12,792
-20,437
-62% -$101K ﹤0.01% 3963
2022
Q1 		$233K Buy
33,229
+32,039
+2,692% +$219K ﹤0.01% 3329
2021
Q4 		$12K Sell
1,190
-29
-2% -$311 ﹤0.01% 3985
2021
Q3 		$15K Buy
+1,219
New +$18.4K ﹤0.01% 4452

Other funds holding MXCT

Capricorn Fund Managers
Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Brooklands Fund Management
Brooklands Fund Management London, United Kingdom $782M AUM 0.49% 1-Year Est. Return
Willis Investment Counsel
Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Cabot Wealth Management
Cabot Wealth Management Salem, Massachusetts $999M AUM 14.8% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
KWMG LLC
KWMG LLC Overland Park, Kansas $1.39B AUM 24.28% 1-Year Est. Return

Barclays's MXCT Position: Q3 2026 in Review

Barclays reduced its MaxCyte (MXCT) stake by 1.1% in Q3 2026, selling an estimated $2.07K and leaving 147,325 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #4074.

Barclays first reported a position in MXCT in Q3 2021 and has held it in 21 quarters since. The position peaked at $700K in Q2 2025. 31 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

  • Barclays held 147,325 shares of MaxCyte worth $165K as of Q3 2026.
  • Barclays sold 1,688 MaxCyte shares in Q3 2026, an estimated $2.07K.
  • MaxCyte made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4074 holding.
  • Barclays first reported a position in MaxCyte in Q3 2021 and has held it in 21 quarters since.
  • Barclays's MaxCyte position peaked at $700K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.